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Symbiotic interactions between eukaryotes and prokaryotes enable both organisms to exploit new environmental niches. Examples of bacterial and fungal interactions range from complex microbial communities in the soil to the rich microbiota of the mammalian gastrointestinal tract. Mutualistic and symbiotic interactions between intracellular bacteria and eukaryotes are hypothesized to have driven the evolution of eukaryotes. The origin of key intracellular organelles, such as mitochondria, chloroplasts and plastids, can be traced to bacterial ancestors [1] . The advantage the eukaryote reaps in terms of energy production seems obvious; however, the advantage to the enslaved bacterium is less clear. In many instances, the genome of the ancestral endosymbiont has been stripped to the core and many essential functions are now encoded by the host eukaryotic nucleus [1] . While this extreme outcome of a symbiotic relationship has been central to eukaryotic evolution, it is not the only possible trajectory. Indeed, the initial encounter between the mitochondrial ancestor and its future host cell likely began as a host-pathogen or predator-prey relationship. Phylogenetic analysis of pathogenic Rickettsia suggests that these bacteria are more closely related to mitochondria than other microbes, and that a common ancestor first invaded proto-eukaryotic cells 1.5-2 billion years ago [2] . In evolution, apparently, there is a fine line between pathogen and symbiont.
The idea that pathogenesis of an organism can be modulated by functions encoded by genetic material from another has been long recognized in bacteria, where lysogenic bacteriophages significantly influence virulence of important human pathogens such as Corynebacterium diphtheria and Vibrio cholera [3] . By extension, given known endosymbiotic bacteria associated with fungi and protists, it would not be surprising if diseases caused by some eukaryotic pathogens are influenced by bacterial endosymbionts.
Partida-Martinez and Hertweck [4] recently established a new paradigm of cross-kingdom symbiotic pathogenesis with their discovery that the production of rhizotoxin, a potent cell-cycle inhibitor secreted by the plant pathogenic fungus Rhizopus microsporus, is dependent upon a bacterial endosymbiont closely related to Burkholderia sp. Strikingly, the isolated Burkholderia produces rhizotoxin when grown in laboratory media, establishing the endosymbiont as the source of this key virulence factor [4] . In an intriguing twist, Hertweck's group [5] has recently reported in Current Biology that vegetative spore production by Rhizopus requires the bacterial endosymbiont. The authors showed that bacteria-free Rhizopus fails to form sporangia or spores, and that microinjected GFP-tagged bacteria migrate to the tips of hyphae and allow new sporangia to form, enabling sporulation. Remarkably, these bacteria become incorporated into single vegetative spores [5] . These simple experiments establish a mechanism for how the endosymbiont ensures its persistence in the fungal-symbiont interaction.
While the fungal host can replicate vegetatively in the absence of its bacterial partner, it cannot sporulate, which should compromise its fitness in nature. In contrast, the Burkholderia endosymbiont, at least in vitro, appears competent for replication in the absence of a eukaryotic host [4] . The interaction between Burkholderia and its fungal host thus appears to straddle a fine line between mutualism -where both organisms benefit from the common exploitation of the plant host -and parasitism, where Rhizopus is held hostage by Burkholderia. A molecular dissection of this interaction may reveal that bacteria-fungus interactions share common features with bacterial pathogens of eukaryotic cells. For instance, type III secretion systems for the translocation of bacterial modulators of eukaryotic cellular functions ('effector proteins') are found in pathogenic Burkholderia [6] . Effector proteins translocated by the type III secretion system of Burkholderia could control a range of interactions with the fungal host, including invasion, intracellular transport of bacteria to hyphal tips and sporulation. It would also not be surprising if the expression or function of fungal virulence factors were to be under direct bacterial control.
Bacteria-fungus interactions extend far beyond endosymbiosis and organellar origins (Figure 1 ). This includes recent, welldocumented examples of horizontal gene transfer from bacteria to fungi, expanding metabolic potential in the recipient fungus via an intimate transkingdom dialog [7] . Other recent experiments have revealed that bacteria such as Pseudomonas aeruginosa interact with and parasitize the hyphae, but not the yeast form, of the most common human fungal pathogen Candida albicans [8] . This bacteria-fungus interaction also involves a conversation, in at least one direction, wherein the fungus perceives and responds to bacterial homoserine lactone quorum sensing molecules [9] . The bacterially derived cell-cell communication molecule inhibits fungal hyphal differentiation, similar to the fungal quorumsensing molecule farnesol [9] . One hypothesis is that this mixed microbial community enables bacteria to interact with fungal hyphae, but at the same time drives the fungus to undergo the dimorphic transition to the yeast form that escapes bacterial predation to seed new tissues and hosts. These examples are only the frontier of a vast landscape of transkingdom interactions, both intracellular and extracellular, that remain to be explored between bacteria and fungi [10] .
A key feature of bacteria that have evolved to survive as intracellular plastids, parasites, endosymbionts or even fastidious species is genome reduction which has jettisoned much of the biosynthetic machinery required for growth in less hospitable environments [11] . Signatures of this cataclysm are apparent in the genomes of a number of such species. It is clear that genome reduction has also occurred in obligate fungal pathogens, including those that survive extracellular and intracellularly. This includes prominently, the microsporidia, which descend from a free-living fungal ancestor but now only find refuge in animal or human cells where they parasitize ATP produced by their host cell [12] . As a consequence, their genome is now only one-fourth to one-third the size of their free-living counterparts. Similarly, the Pneumocystis species, which infect the mammalian lung but cannot be freely cultured, have given up their ability to synthesize ergosterol, a major fungal membrane sterol, and instead usurp cholesterol from their infected host [13] . It may be that their genomes will reveal key insights that might enable them to be cultured in vitro, greatly accelerating experimental efforts for these common microbial pathogens of immunocompromised hosts.
The recent discovery that the fastidious bacteria that causes Whipple's disease lacks biosynthetic enzymes for many amino acids provided the key insight to develop a culture medium enabling axenic culture of the pathogen in the absence of cultured human cells [14] . Similar genomic insights may reveal key evolutionary events that have fashioned other fastidious or obligate microbial pathogens. Alternatively, if the presence of endosymbiotic bacteria in host fungal cells is common, it may emerge that many unculturable bacteria from soil and the mammalian gastrointestinal tract require the hospitality of a host fungal cell.
Intracellular bacteria are also prevalent in environmental isolates of amoeba and protists. Among these bacteria, several human pathogens have been found to survive and proliferate in environmental amoeba [15] . In some instances, the virulence of pathogens such as Legionella pneumophila and Mycobacterium avium is enhanced after passage through an amoeba host which led to the 'Trojan Horse' hypothesis which postulates that environmental amoeba act as conduits to deliver high doses of bacteria 'pre-primed' to infect mammalian macrophages [16] . In contrast, less attention has been devoted to the notion that pathogenic properties of amoeba and other protozoa may be influenced by bacterial endosymbionts. In one example, the severity of amoebal keratinitis has been linked to a bacterial endosymbiont, which increases hemolysis by amoeba [17] .
This example may represent only the tip of an iceberg. The true impact of these endosymbionts on human amoebal and fungal diseases may have been masked by the standard use of antibiotics in prophylaxis [18] . Given the results of Hertweck and colleagues [5] , it would appear timely to revisit the role that bacteria may play in fungal and protozoan diseases of humans, animals and plants. If the role of endosymbiotic bacteria in promoting virulence of host eukaryotic pathogens is a broad one, antibiotics might find an expanded role as adjuvants in the treatment of fungal, amoebal and helminth infections. The yeast pheromone response pathway works in a graded fashion, such that more pheromone leads to more response, but a recent study has shown that small modifications convert it into a bistable switch, with implications for the evolution and engineering of reaction networks. The a-factor branch of this interaction is easier to explore experimentally, so it is the best studied. After a-factor is sensed by cell-surface receptors, the signal is transduced through many steps that eventually result in the activation of so-called pheromone response genes [4] (Figure 1 ). The products of these genes initiate the mating response through cell shape changes, arrested cell division, and other processes.
In wild-type cells, the geneexpression response to a-factor is graded, meaning that the amount of expression increases gradually with increasing amounts of pheromone. It is also reversible, such that gene expression increases when pheromone is added, and decreases when pheromone is removed. Thus, despite the many steps in the
